Literature DB >> 21275265

Cerium oxide nanoparticles: a promise for applications in therapy.

Ivana Celardo1, Enrico Traversa, Lina Ghibelli.   

Abstract

In the last years, increasing biological interest is emerging for nanotechnology that can improve pharmacological treatments, by using nanomaterials. In particular, cerium oxide nanoparticles, considered one of the most interesting nanomaterials for their catalytic properties, show a promise for application in therapy. Due to the presence of oxygen vacancies on its surface and autoregenerative cycle of its two oxidation states, Ce3+ and Ce4+, nanoceria can be used as an antioxidant agent. Because many disorders are associated with oxidative stress and inflammation, cerium oxide nanoparticles may be a tool for the treatment of these pathologies. In this review we analyze the opinions, sometimes conflicting, of the scientific community about nanoceria, together with its capability to protect from various damages that induce cells to death, and to reduce oxidative stress, associated with a consequent reduction of inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21275265

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  27 in total

1.  Layer-by-Layer Cerium Oxide Nanoparticle Coating for Antioxidant Protection of Encapsulated Beta Cells.

Authors:  Nicholas J Abuid; Kerim M Gattás-Asfura; Emily A Schofield; Cherie L Stabler
Journal:  Adv Healthc Mater       Date:  2019-01-11       Impact factor: 9.933

2.  Intravenous and gastric cerium dioxide nanoparticle exposure disrupts microvascular smooth muscle signaling.

Authors:  Valerie C Minarchick; Phoebe A Stapleton; Natalie R Fix; Stephen S Leonard; Edward M Sabolsky; Timothy R Nurkiewicz
Journal:  Toxicol Sci       Date:  2014-12-05       Impact factor: 4.849

3.  Cerium oxide nanoparticles inhibit adipogenesis in rat mesenchymal stem cells: potential therapeutic implications.

Authors:  Antonella Rocca; Virgilio Mattoli; Barbara Mazzolai; Gianni Ciofani
Journal:  Pharm Res       Date:  2014-05-08       Impact factor: 4.200

Review 4.  Neuroprotective potential of cerium oxide nanoparticles for focal cerebral ischemic stroke.

Authors:  Da Zhou; Ting Fang; Lin-Qing Lu; Li Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

5.  Dextran-Coated Cerium Oxide Nanoparticles: A Computed Tomography Contrast Agent for Imaging the Gastrointestinal Tract and Inflammatory Bowel Disease.

Authors:  Pratap C Naha; Jessica C Hsu; Johoon Kim; Shrey Shah; Mathilde Bouché; Salim Si-Mohamed; Derick N Rosario-Berrios; Philippe Douek; Maryam Hajfathalian; Parisa Yasini; Sanjay Singh; Mark A Rosen; Matthew A Morgan; David P Cormode
Journal:  ACS Nano       Date:  2020-07-28       Impact factor: 15.881

6.  Effects of cerium oxide nanoparticles on PC12 neuronal-like cells: proliferation, differentiation, and dopamine secretion.

Authors:  Gianni Ciofani; Giada G Genchi; Ioannis Liakos; Valentina Cappello; Mauro Gemmi; Athanassia Athanassiou; Barbara Mazzolai; Virgilio Mattoli
Journal:  Pharm Res       Date:  2013-05-10       Impact factor: 4.200

7.  Pulmonary cerium dioxide nanoparticle exposure differentially impairs coronary and mesenteric arteriolar reactivity.

Authors:  Valerie C Minarchick; Phoebe A Stapleton; Dale W Porter; Michael G Wolfarth; Engin Çiftyürek; Mark Barger; Edward M Sabolsky; Timothy R Nurkiewicz
Journal:  Cardiovasc Toxicol       Date:  2013-12       Impact factor: 3.231

8.  Biodistribution and PET imaging of 89-zirconium labeled cerium oxide nanoparticles synthesized with several surface coatings.

Authors:  Philip Reed McDonagh; Gobalakrishnan Sundaresan; Likun Yang; Minghao Sun; Ross Mikkelsen; Jamal Zweit
Journal:  Nanomedicine       Date:  2018-04-08       Impact factor: 5.307

9.  Downregulation of tumor growth and invasion by redox-active nanoparticles.

Authors:  Lirija Alili; Maren Sack; Claudia von Montfort; Shailendra Giri; Soumen Das; Kate S Carroll; Klaus Zanger; Sudipta Seal; Peter Brenneisen
Journal:  Antioxid Redox Signal       Date:  2013-01-24       Impact factor: 8.401

Review 10.  Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances.

Authors:  Kevin M Nash; Salahuddin Ahmed
Journal:  Nanomedicine       Date:  2015-08-06       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.